Advertisement

Clinical Evaluation of the Neurophysins as Tumor Markers in Small Cell Lung Cancer

  • W. G. North
  • J. Ware
  • A. P. Chahinian
  • M. Perry
  • J. O’Donnell
  • L. H. Maurer
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 99)

Abstract

Small cell carcinoma of the lung (SCCL) is frequently associated with the ectopic production of peptide hormones, some of which produce significant clinical and laboratory abnormalities in the patient. The syndromes of inappropriate production of antidiuretic hormone (SIADH) and the ectopic secretion of adrenocorticotropic hormone (ACTH) have been well described and occur in 5%–10% of patients suffering from this disease (Kato et al. 1969; Eagan et al. 1974; Lokich 1982). The development of sensitive radioimmunoassays for peptide hormones such as calcitonin, vasopressin, pro-opiomelanocortin and its metabolites (ACTH, lipotropin, B-endorphin), for the neurophysins, and for other proteins, such as carcinoembryonic antigen, neuron-specific enolase, and the BB isoenzyme of creatine kinase, have led to the detection of these substances in SCCL. These peptides and proteins have also been detected in other types of lung cancer, but both the frequency of detection and the quantitative levels are much higher in SCCL. Studies of cell lines of SCCL have contributed to an expansion of the list of hormones detectable in culture. Bombesin is detected in a large percentage of small cell culture lines and may be functioning in an autocrine role (Moody et al. 1981; Sorenson et al. 1982). However, elevated serum levels of bombesin are infrequent (Wood et al. 1982).

Keywords

Tumor Marker Small Cell Lung Cancer Small Cell Carcinoma Extensive Disease Secretory Status 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Eagan RT, Maurer LH, Forcier RJ, Tulloh M (1974) Small cell carcinoma of the lung: Staging, paraneoplastic syndromes, treatment and survival. Cancer 33: 527–532.PubMedCrossRefGoogle Scholar
  2. Chahinian AP, Ware JH, Zimmer B, Comis RL, Perry MC, Hirsch V, Skarin AT, Raich PC, Weiss RB, Carey RW (1984) Evaluation of anticoagulation with warfarin and of alternating chemotherapy in extensive small cell cancer of the lung (SCCL). Proc Am Soc Clin Oncol 3: 225.Google Scholar
  3. Greco FA, Hainsworth J, Sismani A, Richardson RL, Hande KR, Oldham RK (1981) Hormone production and paraneoplastic syndromes. In: Greco FA, Oldham RA, Bunn PA Jr (eds) Small cell lung cancer Grune and Stratton, New York, pp 177–223.Google Scholar
  4. Hamilton BPM, Upton GV, Amatruda TT (1972) Evidence for the presence of neurophysin in tumors producing the syndrome of inappropriate antidiuresis. J Clin Endocrinol Metab 35: 764–767.PubMedCrossRefGoogle Scholar
  5. Kato Y, Ferguson TB, Bennett DE, Burford TH (1969) Oat cell carcinoma of the lung: a review of 138 cases. Cancer 23: 517–524.PubMedCrossRefGoogle Scholar
  6. Land H, Schutz G, Schmale H, Richter D (1982) Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature 295: 299–303.PubMedCrossRefGoogle Scholar
  7. Land H, Grez M, Ruppert S, Schmale H, Rehbein M, Richter D, Schutz G (1983) Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature 302: 342–344.PubMedCrossRefGoogle Scholar
  8. Legros JJ (1975) The radioimmunassay of human neurophysins: contributions to the understanding of the physiopathology of neurohypophyseal function. Ann NY Acad Sci 248: 281–303.PubMedCrossRefGoogle Scholar
  9. Lokich JJ (1982) Frequency and clinical biology of ectopic hormone syndromes of small cell carcinoma. Cancer 50: 2111–2114.PubMedCrossRefGoogle Scholar
  10. Maurer LH, Pajak TF (1981) Prognostic factors in small cell carcinoma of the lung: a CALGB study. Cancer Treat Rep 65: 767–774.PubMedGoogle Scholar
  11. Maurer LH, Tulloh M, Weiss RB, Blom J, Leone L, Glidewell O (1980) A randomized combined modality trial in small cell carcinoma of the lung. Comparison of combination chemotherapy — radiation therapy versus cyclophosphamide — radiation therapy, effects of maintainence chemotherapy and prophylactic whole brain irradiation. Cancer 45: 30–39.PubMedCrossRefGoogle Scholar
  12. Maurer LH, O’Donnell JF, Kennedy S, Faulkner CS, Rist K, North WG (1983) Human neurophysins in carcinoma of the lung: Relation to histology, disease stage, response rate, survival, and the syndrome of inappropriate antidiuretic hormone secretion. Cancer Treat Rep 67: 971–976.PubMedGoogle Scholar
  13. Moody TW, Pert CB, Gazdar AF, Carney DN, Minna JP (1981) High levels of intracellular bombesin characterize human small cell lung carcinoma. Science 214: 246–247.CrossRefGoogle Scholar
  14. North WG, LaRochelle FT, Jr, Melton J, Mills RC (1980a) Isolation and partial characterization of two human neurophysins: their use in the development of specific radioimmunoassays. J Clin Endocrinol Metab 51: 884–889.PubMedCrossRefGoogle Scholar
  15. North WG, Maurer LH, Valtin H, O’Donnell J (1980b) Human neurophysins as potential tumor markers for small cell carcinoma of the lung: Application of specific radioimmunassays for vasopressin-associated and oxytocin associated neurophysins. J Clin Endocrinol Metab 51: 892–896.PubMedCrossRefGoogle Scholar
  16. North WG, Maurer LH, O’Donnell JF (1983a) The neurophysins and small cell lung cancer. In: Greco FA (ed) Biology and management of lung cancer. Nijhoff, Boston, pp 143–169.CrossRefGoogle Scholar
  17. North WG, Valtin H, Cheng S, Hardy GR (1983b) The neurophysins: Production and Turnover. Prog Brain 60: 217–225.CrossRefGoogle Scholar
  18. Perry MC, Eaton WL, Ware J, Zimmer B, Comis R, Chahinian AP, Skarin A, Carey R, Hirsch V (1984) Chemotherapy (CT) with or without radiation therapy (RT) in limited small cell carcinoma of the lung (SCCL). Proc Am Soc Clin Oncol 3: 230.Google Scholar
  19. Ratcliffe JG, Podmore J, Stack BHR, Spilg WGS, Gropp C (1982) Circulating ACTH and related peptides in lung cancer. Br J Cancer 45: 230–236.PubMedCrossRefGoogle Scholar
  20. Robinson AG, Haluszczak C, Wilkins JA, Heullmantel AB, Watson CG (1977) Physiological control of two neurophysins in humans. J Clin Endocrinol Metab 44: 330–339.PubMedCrossRefGoogle Scholar
  21. Sendecor GW, Cochran WG (1967) Statistical methods. Iowa State University Press, Ames.Google Scholar
  22. Sorenson GD, Bloom SR, Ghatei MA, Del Prete SA, Cate CC, Pettengill OS (1982) Bombesin production by human small cell carcinoma of the lung. Regul Pept 4: 59–66.PubMedCrossRefGoogle Scholar
  23. Sorenson GD, Pettengill OS, Brinck-Johnson T, Cate CC, Maurer LH (1981) Hormone production by cultures of small cell carcinoma of the lung. Cancer 47: 289–296.CrossRefGoogle Scholar
  24. Steel RGD, Torrie JH (1980) Principles and procedures of statistics, McGraw Hill, New York.Google Scholar
  25. Teto R, Pike MC, Armatage P, et al (1977) Design and analysis of randomized clinical trials requiring prolonged observations of each patient. Br J Cancer 35: 1–39.CrossRefGoogle Scholar
  26. Wallach SR, Royston I, Taetle R, Wohl H, Deftos LJ (1981) Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung. J Clin Endocrinol Metabol 53: 602–606.CrossRefGoogle Scholar
  27. Wood SM, Wood JR, Ghatei MA, Sorenson GD, Bloom SR (1982) Is bombesin a tumor marker for small cell carcinoma? Lancet 1: 690.PubMedGoogle Scholar
  28. Yamaji T, Ishibashi M, Katayama S (1981) Nature of the immunoreactive neurophysins in ectopic vasopressin-producing oat cell carcinomas of the lung. Demonstration of a putative common precursor to vasopressin and neurophysin. J Clin Invest 68: 388–98.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • W. G. North
    • 1
  • J. Ware
    • 1
  • A. P. Chahinian
    • 1
  • M. Perry
    • 1
  • J. O’Donnell
    • 1
  • L. H. Maurer
    • 1
  1. 1.Department of PhysiologyDartmouth Medical SchoolHanoverUSA

Personalised recommendations